Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

1.51
Delayed Data
As of Jun 22
 +0.01 / +0.67%
Today’s Change
1.28
Today|||52-Week Range
4.47
-13.22%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-19.4M-14.3M-11.8M-7.5M
 
 
 
 
 
Depreciation174.0K210.0K133.0K32.0K
 
 
 
 
 
Total Other Cash Flow1.5M796.0K770.0K266.0K
 
 
 
 
 
Funds From Operations-17.7M-13.3M-10.9M-7.2M
 
 
 
 
 
Funds From/For Other Operating Expenses1.0M1.1M-809.0K308.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-18.7M-14.5M-10.1M-7.5M
 
 
 
 
 
 
InvestingCapital Expenditures-309.0K-34.0K-3.0K-13.0K
 
 
 
 
 
Fixed Asset Disposal----12.0K0.00
 
 
Other Investing - Sources384.0K96.0K0.000.00
 
 
 
Net Cash Flow Investing75.0K62.0K9.0K-13.0K
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale12.4M11.1M6.8M14.9M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total-200.0K-201.0K-200.0K-201.0K
 
 
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing12.2M10.9M6.6M14.7M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-530.0K-211.0K-444.0K135.0K
 
 
 
 
 
 
Net Change In Cash-6.4M-3.5M-3.5M7.3M